Jeffrey L Dupree
Overview
Explore the profile of Jeffrey L Dupree including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
2217
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gow A, Dupree J, Feinstein D, Boullerne A
ASN Neuro
. 2025 Jan;
17(1):2447336.
PMID: 39883092
Despite tremendous progress in characterizing the myriad cellular structures in the nervous system, a full appreciation of the interdependent and intricate interactions between these structures is as yet unfulfilled. Indeed,...
2.
Beiter R, Raghavan T, Suchocki O, Ennerfelt H, Rivet-Noor C, Merchak A, et al.
Heliyon
. 2025 Jan;
11(1):e41635.
PMID: 39866464
Background: Variants in the gene have been identified as a risk factor for late-onset Alzheimer's disease and are linked to decreased white matter integrity in healthy adults. However, the specific...
3.
Jackson K, Zhao D, Su L, Lipp M, Toler C, Idowu M, et al.
Hepatol Commun
. 2025 Jan;
8(12.
PMID: 39773902
Background: Sphingosine-1 phosphate (S1P) is a bioactive lipid molecule that modulates inflammation and hepatic lipid metabolism in MASLD, which affects 1 in 3 people and increases the risk of liver...
4.
Mittra N, He S, Bao H, Bhattacharjee A, Dodds S, Dupree J, et al.
bioRxiv
. 2024 Nov;
PMID: 39605561
Disrupted lipid homeostasis and neuroinflammation often co-exist in neurodegenerative disorders including Alzheimer's disease (AD). However, the intrinsic connection and causal relationship between these deficits remain elusive. Our previous studies show...
5.
Beiter R, Raghavan T, Suchocki O, Ennerfelt H, Rivet-Noor C, Merchak A, et al.
Res Sq
. 2024 Jun;
PMID: 38853911
Background: White matter loss is a well-documented phenomenon in Alzheimer's disease (AD) patients that has been recognized for decades. However, the underlying reasons for the failure of oligodendrocyte progenitor cells...
6.
Pruvost M, Patzig J, Yattah C, Selcen I, Hernandez M, Park H, et al.
Cell Rep
. 2023 Jul;
42(8):112848.
PMID: 37515770
Oligodendrocytes are specialized cells that insulate and support axons with their myelin membrane, allowing proper brain function. Here, we identify lamin A/C (LMNA/C) as essential for transcriptional and functional stability...
7.
He S, Qiu S, Pan M, Palavicini J, Wang H, Li X, et al.
Clin Transl Med
. 2023 Jul;
13(7):e1332.
PMID: 37478300
Background: Despite being a brain disorder, Alzheimer's disease (AD) is often accompanied by peripheral organ dysregulations (e.g., loss of bladder control in late-stage AD), which highly rely on spinal cord...
8.
Qiu S, He S, Wang J, Wang H, Bhattacharjee A, Li X, et al.
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37445661
The interconnection between obesity and central nervous system (CNS) neurological dysfunction has been widely appreciated. Accumulating evidence demonstrates that obesity is a risk factor for CNS neuroinflammation and cognitive impairment....
9.
Dustin E, Suarez-Pozos E, Stotesberry C, Qiu S, Palavicini J, Han X, et al.
Biomedicines
. 2023 May;
11(5).
PMID: 37239102
3-O-sulfogalactosylceramide, or sulfatide, is a prominent myelin glycosphingolipid reduced in the normal appearing white matter (NAWM) in Multiple Sclerosis (MS), indicating that sulfatide reduction precedes demyelination. Using a mouse model...
10.
Palavicini J, Ding L, Pan M, Qiu S, Wang H, Shen Q, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613677
Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive memory loss and a decline in activities of daily life. Ventricular enlargement has been associated with worse performance on global...